NCT04000438 - Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix | Biotech Hunter

Enrollment

365

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

February 14, 2023

Study Completion Date

March 30, 2023

Conditions

Labor Onset and Length Abnormalities

Interventions

DRUG

DF01

DF01: The subject receives sc injections of tafoxiparin solution once daily for up to 7 days until spontaneous onset of labor or ripe cervix (Amniotomy/oxytocin without restriction).If not enough ripening cervical ripening according to clinical practice with intracervical ballon/prostaglandins

DRUG

PL1

DF01: The subject receives sc injections of placebo solution once daily for up to 7 days until spontaneous onset of labor or ripe cervix (Amniotomy/oxytocin without restriction).If not enough ripening cervical ripening according to clinical practice with intracervical ballon/prostaglandins

Trial Locations (7)

11883

Kvinnokliniken Södersjukhuset, Stockholm

33521

Tampere University Hospital, Tampere

54185

Kvinnokliniken Skaraborgs Sjukhus, Skövde

00029

Naistenklinikka (HUS), Helsinki

581 85

Kvinnokliniken Universitetssjukhuset Linköping, Linköping

Unknown

Lund University Hospital, Lund

751 85

Förlossningsavdelningen Akademiska Universitetssjukhuset, Uppsala